SPARSENTAN RECEPTOR OCCUPANCY MODELING, CLINICAL ACTIONS, AND SAFETY

Back

E-Poster

https://storage.unitedwebnetwork.com/files/1099/10103cf45332c05f5665d74df7896cfa.pdf

Abstract Title

First Name *

Bruce

Last Name *

Hendry

Co-author 1

Donald Kohan donald.kohan@hsc.utah.edu University of Utah Health Division of Nephrology, School of Medicine Salt Lake City

Co-author 2

Rob Geletka rob.geletka@travere.com Travere Therapeutics, Inc. Medical Affairs San Diego

Co-author 3

Celia Jenkinson celia.jenkinson@travere.com Travere Therapeutics, Inc. Translational Pharmacology San Diego

Co-author 4

Shang-Chiung Chen charles.chen@zymeworks.com Travere Therapeutics, Inc. Clinical Pharmacology San Diego

Co-author 5

Patricia W Bedard patricia.bedard@travere.com Travere Therapeutics, Inc. Nonclinical Development San Diego

Co-author 6

Co-author 7

Co-author 8

Co-author 9

Co-author 10

Co-author 11

Co-author 12

Co-author 13

Co-author 14

Co-author 15